Hidradenitis suppurativa (HS) is a chronic, relapsing, inflammatory skin disease characterized by painful inflamed nodules, recurrent abscesses and fistulas located in apocrine gland-bearing body sites. The negative impact of HS on patient's quality of life (QoL) has been reported to be greater than other dermatologic conditions as psoriasis and atopic eczema, and its improvement is an important goal in disease management. Nowadays, there are no specific validated QoL instruments available for HS and generic dermatologic questionnaires are used.

HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa / Peris, K; Lo Schiavo, A; Fabbrocini, G; Dini, V; Patrizi, A; Fusano, M; Bianchi, L; Guanziroli, E; Guarneri, C; Parodi, A; Bertoldi, A; Musumeci, M L; Offidani, A; Rongioletti, F; Pistone, G; Malara, G; Potenza, C; Casari, A; Franchi, C; Ardigò, M; Cusano, F; Stingeni, L; Amerio, P; Mancini, L L; Prignano, F; Deboli, T; Gualberti, G; Saragaglia, V; Bettoli, V. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - STAMPA. - 33:4(2019), pp. 766-773. [10.1111/jdv.15425]

HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa

Patrizi, A;
2019

Abstract

Hidradenitis suppurativa (HS) is a chronic, relapsing, inflammatory skin disease characterized by painful inflamed nodules, recurrent abscesses and fistulas located in apocrine gland-bearing body sites. The negative impact of HS on patient's quality of life (QoL) has been reported to be greater than other dermatologic conditions as psoriasis and atopic eczema, and its improvement is an important goal in disease management. Nowadays, there are no specific validated QoL instruments available for HS and generic dermatologic questionnaires are used.
2019
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa / Peris, K; Lo Schiavo, A; Fabbrocini, G; Dini, V; Patrizi, A; Fusano, M; Bianchi, L; Guanziroli, E; Guarneri, C; Parodi, A; Bertoldi, A; Musumeci, M L; Offidani, A; Rongioletti, F; Pistone, G; Malara, G; Potenza, C; Casari, A; Franchi, C; Ardigò, M; Cusano, F; Stingeni, L; Amerio, P; Mancini, L L; Prignano, F; Deboli, T; Gualberti, G; Saragaglia, V; Bettoli, V. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - STAMPA. - 33:4(2019), pp. 766-773. [10.1111/jdv.15425]
Peris, K; Lo Schiavo, A; Fabbrocini, G; Dini, V; Patrizi, A; Fusano, M; Bianchi, L; Guanziroli, E; Guarneri, C; Parodi, A; Bertoldi, A; Musumeci, M L; Offidani, A; Rongioletti, F; Pistone, G; Malara, G; Potenza, C; Casari, A; Franchi, C; Ardigò, M; Cusano, F; Stingeni, L; Amerio, P; Mancini, L L; Prignano, F; Deboli, T; Gualberti, G; Saragaglia, V; Bettoli, V
File in questo prodotto:
File Dimensione Formato  
JDV-33-766.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale (CCBYNC)
Dimensione 253.52 kB
Formato Adobe PDF
253.52 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/687472
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 15
social impact